Search / Trial NCT06233760

Prevalence of Abuse Among Patients With Rheumatic Diseases

Launched by NATIONAL INSTITUTE OF MEDICAL SCIENCES AND NUTRITION, SALVADOR ZUBIRAN · Jan 22, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Rheumatic Diseases Abuse

Description

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes. In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights v...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate
  • Exclusion Criteria:
  • * Patients with a not confirmed rheumatic disease

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Mexico City, , Mexico

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0